HIV and dementia Flashcards
what is HAND?
HIV associated neurocognitive disorders
three further subtypes
HIV 1 ANI- associated asymptomatic neurocognitive impairment
hiv1- MND associated mild neurocognitive disorder
HAD- HIV assoaicted dementia
what is ANI?
acquired impairment in at least two domains ( 1sd below age and education norms)
functional impairment: none
what is MND (HAND)
neuropsychological profile: acquired impairment in at least two domains
functional impairment:
mild interference in functioning
a) self reported
or
b) observations by others
what is HAD
neuropsychological profile:
Acquired impairment in at least two domains with at least two domains with severe impairment (<2SDs)
functional impairment:
Marked interference with daily functioning (work, home, social activities)
what is the epidemiology of HAD
before HAART 21 per 1000
after HAART 10.5 per 1000
the multicentre AIDS cohort study (2001)
what are the symptoms of HAD
generally develop over weeks to month in following domains:
cognition:
decreases attention, forgetfulness, slowing of thought processes global dementia confusion, disorientation organic psychosis
motor:
unsteady gait clumsiness tremor leg weakness loss of coordination/impaired handwriting
behavior
social withdrawal apathy personality change agitation hallucinations
other:
headaches
generalized seizures
ataxia
describe invesigation for HAD
drug history
mood/anxiety
exclude other causes of CI in HIV
(infections ie toxo/ vascular)
CNS penetration effectiveness score
T2 mri
describe treatment for HAD
reduce viral load and activity in CNS
treamtent primarilty cART/HAART
abacivit, zidovudine, nevirapine as best CNS pentration
supportive
prevention
what is the criteria for ANI according to the frascatti criteria 2007
performance at least 1 SD below mean
in at least two domains
at least five domains needs to be examined
impairment does not occur solely as a result of delerium
what is a caveat of the frascatti criteria?
using AAN criteria over 90% of minorities diagnosed compaired to 78% caucasians
in healthy subjects
33% african americans vs 15% white were considered congitively impaired
cART/HAART and HIV dementia
some antiretrovirals aren’t very good at penetrating CNS
poor CPE (CNS penetration effectiveness)
better neurocongitivve functioning measures with higher CPE cART drugs (smurzynski et al 2011)
what is one caveat of cART and HAND?
he persistent high prevalence of less severe forms of HAND, together with some evidence suggesting progressive cognitive dysfunction despite adequate suppression of HIV RNA in plasma and CSF, has raised the possibility of cART neurotoxicity.
a study on rats found that of 15 antiretrovirals tests on rat neurons
only one didn’t cause mitochondrial dysfunction